Although the role of CHI3L1 in the pathogenesis of atherosclerotic vascular disease remains understudied, recent research findings suggest that targeting CHI3L1 may provide a novel therapeutic strategy for atherosclerosis. This evidence concerns the gene CHI3L1 and atherosclerosis.